3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
3
Prostatic Neoplasms
2
Esophageal Neoplasms
2
Cardiotoxicity
2
Stomach Neoplasms
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Lupus Erythematosus, Systemic
1
Lung Neoplasms
1
Hodgkin Disease
1
Gastrointestinal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
sotrovimab
1
ciclesonide
1
cabozantinib
1
anifrolumab
1
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Platinum Compounds
1
Nivolumab
1
Niclosamide
1
Methods
1
Ipilimumab
1
Interviews as Topic
1
Immune Checkpoint Inhibitors
1
High-Intensity Interval Training
1
Exercise
1
Educational Status
1
Early Intervention, Educational
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lupus Erythematosus, Systemic
×
High-Intensity Interval Training
×
1 year
×
Clear all
NCT05478018
2025-09-09
LUPEX
Rigshospitalet, Denmark
Phase NA
Completed
55 enrolled